Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

External validation of prediction models for mortality in an incident dialysis population
.

Mavrakanas TA, Asfour K, Vasilevsky M, Barré PE, Alam A.

Clin Nephrol. 2019 Feb;91(2):65-71. doi: 10.5414/CN109310.

PMID:
30526813
2.

Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD.

Mavrakanas TA, Khattak A, Singh K, Charytan DM.

BMC Nephrol. 2018 Jul 11;19(1):176. doi: 10.1186/s12882-018-0975-5.

3.

Direct Factor Xa Inhibitors for Long-term Stroke Prevention in Atrial Fibrillation: Could the Lower Dose Fit All?

Mavrakanas TA, Sood MM.

Can J Cardiol. 2018 May;34(5):690.e15. doi: 10.1016/j.cjca.2018.02.003. Epub 2018 Feb 7. No abstract available.

PMID:
29731031
4.

Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers.

Mavrakanas TA, Lipman ML.

Can J Diabetes. 2018 Apr;42(2):118-123. doi: 10.1016/j.jcjd.2017.11.006. Epub 2017 Dec 22. Review.

PMID:
29602404
5.

Early versus late initiation of renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomised clinical trials.

Mavrakanas TA, Aurian-Blajeni DE, Charytan DM.

Swiss Med Wkly. 2017 Oct 12;147:w14507. doi: 10.4414/smw.2017.14507. eCollection 2017.

6.

Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography.

Mavrakanas TA, Khattak A, Singh K, Charytan DM.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1624-1633. doi: 10.2215/CJN.04020417. Epub 2017 Aug 11.

7.

Neutropenia in kidney and liver transplant recipients: Risk factors and outcomes.

Mavrakanas TA, Fournier MA, Clairoux S, Amiel JA, Tremblay ME, Vinh DC, Coursol C, Thirion DJG, Cantarovich M.

Clin Transplant. 2017 Oct;31(10). doi: 10.1111/ctr.13058. Epub 2017 Aug 12.

PMID:
28736953
8.

Platelet reactivity in stable cardiovascular patients with chronic kidney disease.

Mavrakanas TA, Alam A, Reny JL, Fontana P.

Platelets. 2018 Jul;29(5):455-462. doi: 10.1080/09537104.2017.1316485. Epub 2017 Jun 5.

PMID:
28580812
9.

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients.

Mavrakanas TA, Samer CF, Nessim SJ, Frisch G, Lipman ML.

J Am Soc Nephrol. 2017 Jul;28(7):2241-2248. doi: 10.1681/ASN.2016090980. Epub 2017 Mar 16.

10.

Cardiovascular complications in chronic dialysis patients.

Mavrakanas TA, Charytan DM.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):536-544. Review.

11.

Serial versus single troponin measurements for the prediction of cardiovascular events and mortality in stable chronic haemodialysis patients.

Mavrakanas TA, Sniderman AD, Barré PE, Alam A.

Nephrology (Carlton). 2018 Jan;23(1):69-74. doi: 10.1111/nep.12945.

PMID:
27718506
12.

High Ultrafiltration Rates Increase Troponin Levels in Stable Hemodialysis Patients.

Mavrakanas TA, Sniderman AD, Barré PE, Vasilevsky M, Alam A.

Am J Nephrol. 2016;43(3):173-8. doi: 10.1159/000445360. Epub 2016 Apr 12.

PMID:
27064739
13.

Bivalirudin in ST-segment-elevation myocardial infarction: for better or worse?

Mavrakanas TA, Chatzizisis YS.

Expert Rev Cardiovasc Ther. 2015;13(8):893-5. doi: 10.1586/14779072.2015.1064311. Epub 2015 Jul 2.

PMID:
26138859
14.

Bivalirudin in stable angina and acute coronary syndromes.

Mavrakanas TA, Chatzizisis YS.

Pharmacol Ther. 2015 Aug;152:1-10. doi: 10.1016/j.pharmthera.2015.04.003. Epub 2015 Apr 7. Review.

PMID:
25857452
15.

Direct oral anticoagulants: efficacy and safety in patient subgroups.

Mavrakanas TA, Samer C, Fontana P, Perrier A.

Swiss Med Wkly. 2015 Feb 6;145:w14081. doi: 10.4414/smw.2015.14081. eCollection 2015. Review.

16.

Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis.

Mavrakanas TA, de Haller R, Philippe J.

Can J Diabetes. 2015 Feb;39(1):18-20. doi: 10.1016/j.jcjd.2014.05.011. Epub 2014 Oct 22.

PMID:
25444679
17.

Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review.

Mavrakanas TA, Gariani K, Martin PY.

Eur J Intern Med. 2014 Feb;25(2):173-6. doi: 10.1016/j.ejim.2013.11.007. Epub 2013 Dec 4. Review.

PMID:
24315413
18.

Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: case report and literature review.

Mavrakanas TA, Bouatou Y, Samer C, de Seigneux S, Meyer P.

Ren Fail. 2013;35(3):414-7. doi: 10.3109/0886022X.2012.760356. Epub 2013 Jan 24. Review.

PMID:
23343442
19.

Severe mitral valve regurgitation in polymyositis.

Mavrakanas TA, Lobrinus A, Berdagué P, Seebach JD, Reny JL.

J Clin Rheumatol. 2012 Oct;18(7):367-9. doi: 10.1097/RHU.0b013e31826d1e2c. Review. No abstract available.

PMID:
23047538
20.

Effect of ramipril alone compared to ramipril with eplerenone on diabetic nephropathy in streptozocin-induced diabetic rats.

Mavrakanas TA, Cheva A, Kallaras K, Karkavelas G, Mironidou-Tzouveleki M.

Pharmacology. 2010;86(2):85-91. doi: 10.1159/000316113. Epub 2010 Aug 6.

PMID:
20689340
21.

A prospective study of acute poisonings in a sample of Greek patients.

Exiara T, Mavrakanas TA, Papazoglou L, Papazoglou D, Christakidis D, Maltezos E.

Cent Eur J Public Health. 2009 Sep;17(3):158-60.

22.

Transient glycosuria during a urinary tract infection.

Mavrakanas TA, Tomos C, Pratsiou P, Seventekidou I, Tzouvelekis G.

Presse Med. 2010 Jan;39(1):145-6. doi: 10.1016/j.lpm.2009.09.002. Epub 2009 Oct 21. No abstract available.

PMID:
19846272
23.

Childhood obesity and elevated blood pressure in a rural population of northern Greece.

Mavrakanas TA, Konsoula G, Patsonis I, Merkouris BP.

Rural Remote Health. 2009 Apr-Jun;9(2):1150. Epub 2009 Jun 25.

24.

Prevalence of myopia in a sample of Greek students.

Mavrakanas TA, Mandalos A, Peios D, Golias V, Megalou K, Gregoriadou A, Delidou K, Katsougiannopoulos B.

Acta Ophthalmol Scand. 2000 Dec;78(6):656-9. Erratum in: Acta Ophthalmol Scand. 2016 Dec;94(8):746.

Supplemental Content

Loading ...
Support Center